Levels of toxins in oral tobacco products in the UK

Objective: This study examined the constituents of smokeless tobacco products available in the UK and compared them with products available in India, Sweden, and the USA Methods: Seven UK brands of smokeless tobacco, including a tooth cleaning powder, and four international brands of smokeless tobacco were tested for a range of toxins and known carcinogens, such as tobacco specific N-nitrosamines (TSNA), as well as nicotine availability. Results: Ten of the 11 brands tested had detectable levels of tobacco specific nitrosamines, which are proven carcinogens, and levels varied 130-fold. All had detectable levels of benzo(a)pyrene, another proven carcinogen (with around 175-fold variation) and several toxic metals (with nearly 150-fold variation). Nicotine availability varied in the UK products from 0.1 mg/g to 63.2 mg/g. All the tobacco products tested are likely to be hazardous to users’ health, but the data indicate that it should be possible to reduce key toxins to non-detectable levels. Conclusions: Smokeless tobacco products should be regulated and standards set for maximum levels of toxins and carcinogens.

[1]  K. Fagerström,et al.  European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health , 2003, Tobacco control.

[2]  R. Bedi,et al.  The prevalence of betel-quid and tobacco chewing among the Bangladeshi community resident in a United Kingdom area of multiple deprivation. , 1995, Primary dental care : journal of the Faculty of General Dental Practitioners.

[3]  D. Hatsukami,et al.  Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. , 2004, Journal of the National Cancer Institute.

[4]  G. Connolly,et al.  Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. , 1995, Journal of the National Cancer Institute.

[5]  M. Raw,et al.  Smokeless tobacco cessation guidelines for health professionals in England , 2004, British Dental Journal.

[6]  Stephen S Hecht,et al.  Tobacco‐specific nitrosamines in smokeless tobacco products marketed in India , 2005, International journal of cancer.

[7]  R. Wallace,et al.  Clearing the smoke: assessing the science base for tobacco harm reduction. , 2001 .

[8]  M. Djordjevic,et al.  Effects of storage conditions on levels of tobacco-specific N-nitrosamines and N-nitrosamino acids in U.S. moist snuff , 1993 .

[9]  B. Osterdahl,et al.  Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. , 2004, Journal of agricultural and food chemistry.

[10]  D. Hoffmann,et al.  Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. , 1991, Critical reviews in toxicology.

[11]  P. Gupta,et al.  INVITED REVIEW SERIES: TOBACCO AND LUNG HEALTH Smokeless tobacco and health in India and South Asia , 2003 .

[12]  D. Hoffmann,et al.  Chemical profile of two types of oral snuff tobacco. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.